CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 97,276 shares at $5.04 ($490,271)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP and CSO acquired 4,526 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,862 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 15,329 shares (grant or award)
- 4 Grant or award EVP, CLO and CCO acquired 5,475 shares (grant or award)
- 4 Grant or award EVP and Chief Medical Officer acquired 4,526 shares (grant or award)
- 4 Open-market buy Director bought 19,455 shares at $5.04 ($98,053)
- 4 Open-market buy SVP and CFO bought 4,864 shares at $5.04 ($24,515)
Page 1 of 9 · 175 filings